Non-infectious and unusual infectious mimics of community-acquired pneumonia

José Wellington Alves dos Santos1, Antoni Torres, Gustavo Trindade Michel

  • 1Serviço de Pneumolgia, Hospital Universitário de Santa Maria, Universidade Federal de Santa Maria, Rua Venâncio Aires 2020/403, Santa Maria 97010-004, RS, Brazil. well@vant.com.br

Respiratory Medicine
|June 12, 2004
PubMed

Insights

Noninfectious or unusual infectious diseases can mimic community-acquired pneumonia (CAP), leading to delayed diagnosis and treatment. Suspecting these conditions in treatment-refractory CAP cases is crucial for effective patient management.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Pathology

Background:

  • Community-acquired pneumonia (CAP) is commonly diagnosed, but noninfectious or unusual infectious diseases can present with similar symptoms.
  • Delayed diagnosis of these mimics leads to ineffective treatments, increased costs, and risks from untreated serious conditions.

Purpose of the Study:

  • To identify noninfectious and unusual infectious diseases misdiagnosed as CAP with treatment failure.
  • To highlight the importance of considering alternative diagnoses in refractory CAP cases.

Main Methods:

  • Retrospective analysis of 16 hospitalized patients with a presumptive CAP diagnosis and treatment failure.
  • Diagnostic methods included autopsy, open lung biopsy, flexible fiberoptic bronchoscopy, transthoracic fine needle aspiration, and bone marrow aspiration.

Main Results:

  • Fever and cough were the most common symptoms; 62% showed an air-space disease pattern on imaging.
  • Eight patients had noninfectious diseases (e.g., pulmonary embolism, organizing pneumonia, Wegener's granulomatosis, malignancy).
  • Five patients had unusual infectious diseases (e.g., tuberculosis, fungal infections).

Conclusions:

  • Noninfectious or unusual infectious diseases can mimic CAP presentations.
  • These conditions should be suspected in patients with treatment-refractory CAP, particularly younger individuals or those without comorbidities.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...